Danaher Partners with Beijing's Shunyi District Government to Accelerate Localization of Pall's Biopharmaceutical Single-Use Technologies

BEIJING, Sept. 3, 2021 /PRNewswire/ -- On Sept. 3, 2021, at the Beijing Day of the 2021 China International Fair for Trade in Services (CIFTIS) and the thematic event marking the first anniversary of the "Two Zones" development, Danaher, a global innovator in science and technology, signed a strategic cooperation agreement with the Government of Shunyi District, Beijing, to jointly advance the local production of Pall's single-use biopharmaceutical technologies.This collaboration between the two parties will serve as a positive catalyst for driving regional employment, promoting local economic development, and fostering the clustered development of upstream and downstream industries.

Zheng Wantong, President of the China Association of Transnational Corporations, Wang Wentao, Minister of Commerce, Chen Jining, Deputy Secretary of the Beijing Municipal Committee of the Communist Party of China and Mayor of Beijing, Wang Shouwen, Vice Minister of Commerce and Deputy International Trade Negotiator, Xin Guobin, Vice Minister of Industry and Information Technology, Zhang Jiaming, Member of the Standing Committee of the Beijing Municipal Party Committee and Secretary-General, Yang Jinbai, Vice Mayor of Beijing, Jin Wei, Vice Mayor of Beijing, and others attended the themed event and witnessed the signing ceremony,Yin Yong, Member of the Standing Committee of the Beijing Municipal Party Committee and Vice Mayor of Beijing, presided over the event.

Danaher and Beijing Shunyi District Government Sign Strategic Partnership to Jointly Advance Localized Production of Pall’s Biopharmaceutical Single-Use Technology

Continuously Upgrade Local ProductionEmpowering China's Biopharmaceutical Industry

BasisUnder the strategic cooperation agreement signed between Danaher and the Shunyi District Government, Danaher will invest $60 million to expand the production capacity at the Pall Shunyi production base. Meanwhile, leveraging the China International Fair for Trade in Services (CIFTIS) as an opportunity, the Shunyi District Government will continuously optimize the business environment and provide industrial policy support to facilitate the rapid expansion of Pall's operations in Shunyi District. The Pall Shunyi production base capacity expansion project has been listed as a "Key Project for Beijing's 'Two Zones' Construction".

Gong Zongyuan, Deputy Secretary of the Shunyi District Party Committee and District Mayor, and Li Bing, President of Danaher Life Sciences China, jointly completed the signing ceremony. During the event, Gao Peng, Secretary of the Shunyi District Party Committee, and District Mayor Gong Zongyuan were briefed on the company's product research and development and production line expansion. They welcomed Danaher's commitment to establishing a firm presence in Shunyi, leveraging its multifaceted advantages in talent, technology, and platforms to drive the district's industrial transformation and upgrading. The district government will also provide first-class services and a premium business environment to support the company's continued growth and new development in Shunyi.

In April this year, Pall China’s single-use technology production base in Shunyi District, Beijing, officially commenced operations. As the first single-use technology manufacturing facility established in Asia by Pall Group under Danaher’s Life Sciences platform, it aims to leverage Pall’s advanced production capacity and technology, along with its extensive expertise in single-use systems, to accelerate the time-to-market for vaccines and biologics. From facility acquisition to the shipment of the first batch of products, the Pall project team applied the Danaher Business System (DBS) methodology, completing the site selection, design, construction, validation, and commissioning of a high-grade cleanroom spanning over 1,000 square meters in less than four months. The facility features the highest-standard cleanroom among comparable production lines in China, and its initial shipment is entirely dedicated to supplying China’s COVID-19 vaccine programs.

Li Bing, President of Danaher Life Sciences China, stated: “It is a great honor to leverage this CIFTIS as a pivotal opportunity to establish a strategic partnership with the Beijing Shunyi District Government. The commencement of production at the Pall Shunyi production base is merely the beginning of our accelerated localization efforts. Danaher Corporation will continue to increase its sustained investment in the Chinese market, supporting precision medicine research and accelerating the translation of research outcomes. By leveraging industry-leading technologies and comprehensive solutions, we will inject new momentum into the high-quality development of the biopharmaceutical industry, empower biopharmaceutical companies in China to go global, and accelerate the high-level opening-up of the Chinese market.”

Accelerate the Regional Localization ProcessSupporting the Development of Beijing's "Two Zones"

The development of the "Two Zones" is a major strategic decision by the central government to support Beijing in expanding opening-up, and an important deployment for China to foster a new development paradigm and promote comprehensive opening-up. On the first anniversary of the "Two Zones" initiative, multiple breakthrough projects have taken root in Shunyi District, Beijing, gathering high-quality innovative enterprises and accelerating the district's pace in building a new highland for the international medical and health industry.

Building upon the "Two Zones" (National Comprehensive Demonstration Zone for Expanding the Opening-up of the Service Sector and China (Beijing) Pilot Free Trade Zone), the industrial development in Shunyi District, Beijing, has gradually taken on a high-end, service-oriented, clustered, integrated, and low-carbon trajectory. Three major biomedical industry clusters have currently taken shape: the Northern Biomedical Innovation Zone, the Southern Biomedical Leading Zone, and the Smart Medical Service Center of the Biomedical Health Service Platform. To implement the innovation-driven development strategy and the concept of high-quality development, and to advance the 14th Five-Year Plan for Beijing's High-end, Precision and Advanced Industries, Shunyi District continues to consolidate and expand new growth drivers for the biomedical sector.

Wei Chunyan, Vice President of Government Affairs for Danaher China, said: "The theme of this year's CIFTIS Beijing Day‘Open Empowerment, Global Integration’“This aligns perfectly with Danaher’s steadfast vision to empower China’s broader healthcare industry. Looking ahead, Danaher will continue to be driven by localized technological innovation, remain firmly rooted in the Chinese market, establish a more open collaborative platform, actively integrate into the new economic development paradigm of the capital, and help accelerate the development of China’s pharmaceutical industry.”